Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
about
Prevalence of Hepatitis B Co-Infection among HIV Positive Patients: Narrative Review ArticleVirological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis.Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.Evaluating Liver Fibrosis by Transient Elastometry in Patients With HIV-HCV Coinfection and Monoinfection.The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi.Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in CambodiaHuman immunodeficiency virus infection and the liverLow frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda.Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis.Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis.Accounting for baseline differences and measurement error in the analysis of change over time.Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China.Hepatitis C in Cameroon: What is the progress from 2001 to 2016?
P2860
Q26852495-1C9AFA1E-5012-4D83-BAF3-DC75A7F7BFD2Q33584656-C3406A59-7DC3-41D3-BA9D-122A4FBC09A7Q34157953-EC8B0ECE-98CE-47D7-A0F3-1F09E60554AEQ34349036-A04AE024-8248-410F-B013-0C4467425F13Q34523530-B01AD879-27AC-4DCB-85FF-FA49F7864248Q35095416-3C5F9FA0-717B-4BAD-8A63-11B108FD6102Q35875848-F615C5D5-EEB8-46F8-97D8-D94EA1FB2943Q37043248-A101AA5F-560C-4D05-AD86-283B664ED249Q38603176-B469CFDD-7F38-46CB-A6F8-086ADB96444DQ38699272-998E7080-539E-4CF4-A3C6-A801ADAA2B33Q42280357-4D3D7F57-A4DC-4144-B66E-2C841DD88666Q44174121-1270AC5D-4499-4F0E-B996-D886656AAFE9Q56992646-DB92959B-45EB-45F2-8A38-9C18DEE8D840
P2860
Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Hepatotoxicity and effectivene ...... B or C infection in Cameroon.
@ast
Hepatotoxicity and effectivene ...... B or C infection in Cameroon.
@en
Hepatotoxicity and effectivene ...... B or C infection in Cameroon.
@nl
type
label
Hepatotoxicity and effectivene ...... B or C infection in Cameroon.
@ast
Hepatotoxicity and effectivene ...... B or C infection in Cameroon.
@en
Hepatotoxicity and effectivene ...... B or C infection in Cameroon.
@nl
prefLabel
Hepatotoxicity and effectivene ...... B or C infection in Cameroon.
@ast
Hepatotoxicity and effectivene ...... B or C infection in Cameroon.
@en
Hepatotoxicity and effectivene ...... B or C infection in Cameroon.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Hepatotoxicity and effectivene ...... B or C infection in Cameroon.
@en
P2093
Anke Bourgeois
Christian Laurent
Jacques Ducos
Jules B Tchatchueng Mbougua
Laura Ciaffi
Nicolas Molinari
P2860
P2888
P356
10.1186/1471-2458-10-105
P407
P577
2010-03-01T00:00:00Z
P5875
P6179
1012225454